Healthy Choices

The Muscle-Boosting Molecule Changing How We Age—with Jim LaValle

·25 min·2 clips
Jim LaValle reveals how OSO1 activates AMPK to combat muscle loss and regulate mTOR for safe, anabolic effects.
The episode begins with host Ray Solano introducing Dr. Jim LaValle, a pharmacist and educator involved with A4M and Lifetime. LaValle defines small molecules as organic compounds under 900 Daltons, often from natural sources, and notes their dominance in pharmaceuticals. He introduces OSO1, highlighting its ability to cross the blood-brain barrier and cell membranes for oral efficacy. LaValle details OSO1's mechanisms: activating AMPK for mitochondrial metabolism and anabolic drive, regulating mTOR to maintain lean mass without uncontrolled growth, and inducing autophagy for cellular waste removal. He lists additional benefits, including cardiovascular support, renal protection, redox activity to reduce oxidative stress, and pain and inflammation signaling reduction. LaValle emphasizes OSO1's pleiotrophic effects across body systems for homeostasis. Practical aspects are covered: dosage is 100 milligrams, taken without food, in cycles of 4-8 weeks on and 4 weeks off. It is not a stimulant and works by repairing mechanisms affected by metabolic inflammation from lifestyle factors. LaValle discusses OSO1's synergy with GLP-1 drugs for weight loss, countering lean mass loss, and its importance for kidney health by reducing oxidative stress and senescence. He notes its relevance for all ages, from young people with metabolic dysregulation to seniors with sarcopenia, and its potential for athletes to enhance recovery through post-exercise autophagy. The episode concludes with availability information via PD Labs and LaValle's practice, along with updates on his upcoming books.

As heard by us

A practitioner-led discussion of OSO1, metabolic inflammation, and muscle support alongside appetite reduction.

Healthy Choices centers OSO1 in a discussion of aging biology, as Jim LaValle explains how metabolic inflammation can interfere with the body's signaling.

Read the full review in PlayNext →

Why you'd press play

Want a clearer read on OSO1, metabolic inflammation, and why muscle support comes up around GLP-1 drugs?

Read the full recommendation in PlayNext →
Listen to the show on